As an immunohistochemical proxy for HPV infection, p16 overexpression is now used to subgroup HNSCC of the oropharynx into p16 positive and p16 negative in the TNM-classification of malignant tumors [5,6,7]. The gene discussed is CDKN2A; the disease is cancer.